[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"detail-sidebar-cat-0-en-105":3,"doc-seo-367715-105":59,"doc-detail-367715-en":130},{"code":4,"msg":5,"data":6},0,"success",[7,13,18,23,28,33,38,43,48,51,55],{"id":8,"doc_module":4,"doc_module_name":9,"category_name":10,"show_sort_weight":11,"slug":12},1,"Document","Story & Novel",90,"story-novel",{"id":14,"doc_module":4,"doc_module_name":9,"category_name":15,"show_sort_weight":16,"slug":17},2,"Literature",80,"literature",{"id":19,"doc_module":4,"doc_module_name":9,"category_name":20,"show_sort_weight":21,"slug":22},4,"Exam",70,"exam",{"id":24,"doc_module":4,"doc_module_name":9,"category_name":25,"show_sort_weight":26,"slug":27},5,"Comic",60,"comic",{"id":29,"doc_module":4,"doc_module_name":9,"category_name":30,"show_sort_weight":31,"slug":32},6,"Technology",50,"technology",{"id":34,"doc_module":4,"doc_module_name":9,"category_name":35,"show_sort_weight":36,"slug":37},7,"Healthcare",40,"healthcare",{"id":39,"doc_module":4,"doc_module_name":9,"category_name":40,"show_sort_weight":41,"slug":42},8,"Research & Report",30,"research-report",{"id":44,"doc_module":4,"doc_module_name":9,"category_name":45,"show_sort_weight":46,"slug":47},9,"Religion & Spirituality",20,"religion-spirituality",{"id":46,"doc_module":4,"doc_module_name":9,"category_name":49,"show_sort_weight":46,"slug":50},"World Cup","world-cup",{"id":52,"doc_module":4,"doc_module_name":9,"category_name":53,"show_sort_weight":52,"slug":54},10,"Lifestyle","lifestyle",{"id":56,"doc_module":4,"doc_module_name":9,"category_name":57,"show_sort_weight":24,"slug":58},19,"General","general",{"code":4,"msg":60,"data":61},"ok",{"site_id":62,"language":63,"slug":64,"title":65,"keywords":66,"description":67,"schema_data":68,"social_meta":123,"head_meta":125,"extra_data":127,"updated_unix":129},105,"en","synergistic-effect-of-mir-383-and-cisplatin-on-inhibition-of-growth-proliferation-and-migration-of-lung-cancer-cells","Synergistic Effect of miR-383 and Cisplatin on Inhibition of Growth, Proliferation, and Migration of Lung Cancer Cells","","Background: Lung cancer is a life-threatening malignancy, and cisplatin is widely used but limited by dose-limiting toxicity and drug resistance. miR-383 is dysregulated across multiple cancers and contributes to apoptosis, proliferation, metastasis, and therapy resistance. Methods: A549 cells were treated with cisplatin and miR-383 alone or in combination; viability, apoptosis, stemness, migration, autophagy, and gene expression were evaluated. Results: miR-383 increased cisplatin chemosensitivity, enhanced apoptosis, reduced migration and colony formation, and downregulated MMP-2 and CD44. Conclusion: The combination suppresses proliferation and migration while improving chemotherapy sensitivity, supporting further investigation for lung cancer treatment.",{"@graph":69,"@context":122},[70,84,105],{"@type":71,"itemListElement":72},"BreadcrumbList",[73,77,79,82],{"item":74,"name":75,"@type":76,"position":8},"https://docshare.wps.com","Home","ListItem",{"item":78,"name":9,"@type":76,"position":14},"https://docshare.wps.com/document/",{"item":80,"name":40,"@type":76,"position":81},"https://docshare.wps.com/document/research-report/",3,{"item":83,"name":65,"@type":76,"position":19},"https://docshare.wps.com/document/synergistic-effect-of-mir-383-and-cisplatin-on-inhibition-of-growth-proliferation-and-migration-of-lung-cancer-cells/367715/",{"url":83,"name":65,"@type":85,"image":86,"author":91,"headline":65,"publisher":94,"fileFormat":97,"inLanguage":63,"description":67,"dateModified":98,"datePublished":99,"encodingFormat":97,"isAccessibleForFree":100,"interactionStatistic":101},"DigitalDocument",{"url":87,"@type":88,"width":89,"height":90},"https://docshare.wps.com/thumbnails/synergistic-effect-of-mir-383-and-cisplatin-on-inhibition-of-growth-proliferation-and-migration-of-lung-cancer-cells/367715.png","ImageObject",300,407,{"name":92,"@type":93},"eBook King","Person",{"url":74,"name":95,"@type":96},"DocShare","Organization","application/pdf","2026-10-25","2026-09-23",true,{"@type":102,"interactionType":103,"userInteractionCount":39},"InteractionCounter",{"@type":104},"ViewAction",{"@type":106,"mainEntity":107},"FAQPage",[108,114,118],{"name":109,"@type":110,"acceptedAnswer":111},"What was the study’s main objective regarding miR-383 and cisplatin?","Question",{"text":112,"@type":113},"To investigate the synergistic effect of miR-383 and cisplatin on inhibiting lung cancer cell growth, proliferation, and migration.","Answer",{"name":115,"@type":110,"acceptedAnswer":116},"How were A549 lung cancer cells treated in the experiments?",{"text":117,"@type":113},"Cells were treated with cisplatin and miR-383 separately or in combination.",{"name":119,"@type":110,"acceptedAnswer":120},"What were the key outcomes of the combination therapy?",{"text":121,"@type":113},"The combination increased cisplatin-induced apoptosis, reduced cell migration and colony formation, and downregulated metastasis- and stemness-related genes including MMP-2 and CD44.","https://schema.org",{"og:url":83,"og:type":124,"og:title":65,"og:site_name":95,"og:description":67},"article",{"robots":126,"canonical":83},"index,follow",{"doc_id":128,"site_id":62},367715,1790645845,{"code":4,"msg":5,"data":131},{"doc_id":128,"user_id":132,"nickname":92,"user_avatar":133,"doc_module":4,"category_id":39,"category_name":40,"doc_title":65,"doc_description":67,"doc_content":134,"file_id":135,"file_url":136,"file_type":137,"file_size":138,"view_count":39,"is_deleted":4,"is_public":8,"is_downloadable":8,"audit_status":8,"page_count":139,"language":140,"language_code":63,"site_id":62,"html_lang":63,"table_of_contents":141,"faqs":142,"seo_title":143,"seo_description":67,"update_tm":144,"read_time":145,"preview_page_count":19,"preview_urls":146},962088006270,"https://ap-avatar.wpscdn.com/davatar_085a072bc5b1113ac321206ff7593b45","ARCHIVES OF  \nArch Iran Med. May 2025;28(5):264-274  IRANIAN  \ndoi 10 .34172/aim.33450 [http://journalaim.com](http://journalaim.com MEDICINE)[ MEDICINE](http://journalaim.com MEDICINE)  \nOriginal Article   \nOpen Access  \nSynergistic Effect of miR-383 and Cisplatin on Inhibition of Growth, Proliferation, and Migration of Lung Cancer Cells  \nVagef Elyaszadeh1\\# ID , Maryam Tohidast2\\# ID , Seyed Samad Hosseini2, Mohammad Amini2, Parinaz Marami1, Behzad Baradaran2, Amir Ali Mokhtarzadeh2* ID , Asiyeh Jebelli3* ID  \n1 Department of Biological Science, Faculty of Basic Science, Higher Education Institute of Rab-Rashid, Tabriz, Iran 2 Immunology Research Center, Tabriz University of Medical Sciences, Tabriz, Iran  \n3 Department of Cell and Molecular Biology, Faculty of Biological Sciences, Kharazmi University, Tehran, Iran  \nAbstract  \nBackground: Lung cancer (LC) is a common life-threatening malignancy in humans. Cisplatin has been widely used in the treatment of various types of cancer. miR-383 is dysregulated in multiple cancers, and participates in tumorigenic processes, including apoptosis, proliferation, metastasis, and drug resistance. This study aimed to investigate the synergistic effect of miR-383 and cisplatin in LC.  \nMethods: A549 cells were treated with cisplatin and miR-383 separately or in combination. Cell viability, apoptosis induction, stemness features, migratory capacity, and autophagy were measured by various methods. In addition, quantitative real-time PCR (qRT‐PCR) was used to evaluate the expression levels of genes involved in apoptosis, stemness, and migration.  \nResults: The results demonstrated that miR-383 transfection in A549 cells increased their chemosensitivity to cisplatin, enhancing cisplatin-induced apoptosis (from 11.28% to 37.86%). This effect was mediated by regulating key genes such as Bcl-2 and Caspase-3 (P \u003C 0.0001) . Moreover, the combination of miR-383 and cisplatin synergistically reduced cell migration and colony formation. It also downregulated metastatic and stemness-related genes, including MMP-2 and CD44, respectively (P \u003C 0.0001) .  \nConclusion: The findings indicate that the combination treatment of miR-383 and cisplatin suppressed cell proliferation, migration and colony formation while enhancing the sensitivity of A549 cells to chemotherapy compared to monotherapy. These results suggest that miR-383 combination therapy warrants further investigation as a potential strategy for LC treatment.  \nKeywords: Apoptosis, Cisplatin, Combination therapy, Lung cancer, miR-383  \nCite this article as: Elyaszadeh V, Tohidast M, Hosseini SS, Amini M, Marami P, Baradaran B, et al. Synergistic effect of miR-383 and cisplatin on inhibition of growth, proliferation, and migration of lung cancer cells. Arch Iran Med. 2025;28(5):264-274 . doi:  \n10.34172/aim.33450  \nReceived: November 5, 2024, Revised: February 19, 2025, Accepted: February 26, 2025, ePublished: May 1, 2025  \nIntroduction  \nLung cancer (LC) is one of the most frequently diagnosed malignancies, accounting for approximately 2.2 million newincidentcasesandresultinginanestimated1.79million fatalities annually, making it the primary contributor to global cancer-related mortality. Overall, LC causes more deaths than colorectal, breast, prostate, and brain cancers combined. The two main types of LC are small cell lung cancer (SCLC) and non-SCLC (NSCLC) . SCLC comprises about 15%, and NSCLC accounts for approximately 85% of all cases of LC.1-3 Despite improvements in clinical treatment and surveillance strategies, LC has a poor prognosis. Risk factors for NSCLC have been recognized, and smoking was identified as the main factor along with other genetic and environmental risk factors. Current treatment options for LC depend on the stage of cancer development, and LC patients receive certain treatments including surgery, radiotherapy, chemotherapy, and targeted therapy.4 Cisplatin and other platinum-based anticancer drugs have been used widely","cbCair1fC9ND78Fo","https://ap.wps.com/l/cbCair1fC9ND78Fo","pdf",2585159,11,"English","# Abstract\n# Introduction\n# Materials and Methods\n# Results\n# Conclusion\n# Keywords\n# References","[{\"question\":\"What was the study’s main objective regarding miR-383 and cisplatin?\",\"answer\":\"To investigate the synergistic effect of miR-383 and cisplatin on inhibiting lung cancer cell growth, proliferation, and migration.\"},{\"question\":\"How were A549 lung cancer cells treated in the experiments?\",\"answer\":\"Cells were treated with cisplatin and miR-383 separately or in combination.\"},{\"question\":\"What were the key outcomes of the combination therapy?\",\"answer\":\"The combination increased cisplatin-induced apoptosis, reduced cell migration and colony formation, and downregulated metastasis- and stemness-related genes including MMP-2 and CD44.\"}]","Synergistic Effect of miR-383 and Cisplatin on Inhibition of Growth, Proliferation, and Migration of Lung Cancer Cells | PDF",1790172196,28,[147,151,155,159],{"page_no":8,"url":148,"width":149,"height":150},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/584e21d14fb27d9e33e6a27037b7de89.webp",983,1390,{"page_no":14,"url":152,"width":153,"height":154},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/449660410c6ac4089fd769722332eb03.webp",982,1388,{"page_no":81,"url":156,"width":157,"height":158},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/cd770f77db515aba7cd4aedda0c5c16b.webp",981,1387,{"page_no":19,"url":160,"width":161,"height":162},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/1d1b90776138b4fa4cf694dcc6ca42cf.webp",980,1385]